By Dr. Sanchari Sinha Dutta, Ph.D.Reviewed by Lily Ramsey, LLM Bioactive compounds and metabolites in mushroomsMushrooms in ancient healingEdible mushrooms with therapeutic potency Fungi have gained significant attention in the field of phytomedicine as potential natural sources of bioactive compounds and secondary metabolites. Fungi that produce visible fruiting bodies are called macrofungi. Mushrooms are edible...
Self-copying RNA vaccine wins first full approval: what’s next?
Researchers look ahead to the potential uses and benefits of a technology that has been more than 20 years in the making. Elie Dolgin Self-amplifying RNA vaccines will add to the arsenal of conventional messenger RNA jabs.Credit: Pascal Pochard-Casabianca/AFP via Getty The approval of yet another RNA-based vaccine for COVID-19 might not seem momentous. But...
Hard to Drug: Protein Droplets Reveal New Ways to Inhibit Aggressive Form of Prostate Cancer
Many of the most potent human oncoproteins belong to a class of proteins called transcription factors, but designing small molecule drugs that target transcription factors is a major challenge, especially when treating aggressive forms of prostate cancer. An international team of researchers from the Institute for Research in Biomedicine in Barcelona, the Max Planck Institute...
Scientists Use Quantum Biology, AI to Sharpen Genome Editing Tool
Scientists at Oak Ridge National Laboratory used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.ORNL scientists developed a method that improves the accuracy of the CRISPR Cas9 gene editing tool used...
Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms
Researchers at the University of Pennsylvania have developed nanorobots that can travel to the site of a fungal infection under the influence of an external magnetic field, bind to the fungal cells, and then release reactive oxygen species to completely destroy the fungus. The tiny particles are an example of catalytic nanoparticles, which the researchers...
AI DIY Medical Pod
Forward’s CarePod stand-alone doctor’s office. Photo: Courtesy of Forward Now coming to a mall, gym or office building near you: A self-contained doctor’s office, powered by artificial intelligence, where you — the patient — draw your own blood and take your own vitals, Jennifer reports. Why it matters: The traditional annual checkup is being disrupted...
Cocoa extract supplement found to have benefits for cognition among older adults with lower diet quality
Peer-Reviewed Publication MASS GENERAL BRIGHAM WHO: Mass General Brigham researchers, Dr. Chirag Vyas and Dr. Olivia I. Okereke at Massachusetts General Hospital, and Dr. Howard Sesso and Dr. JoAnn Manson at Brigham and Women’s Hospital WHAT: Cocoa extract has shown a potential protective effect on cognition but randomized clinical trials in older adults have had...
XoMotion to be World’s Most Advanced Exoskeleton for Mobility Challenged
Next-generation exoskeleton technology XoMotion developed by SFU researchers is poised to offer people living with mobility challenges a new chance at free and independent movement. Left to right: Ed Park, Siamak Arzanpour, and Chloe Angus. Image credit: Simon Fraser University The state-of-the-art robotic exoskeleton known as XoMotion is the result of a decade of research...
Novo Nordisk Stops Ozempic Kidney Trial After Early Signs of Success
By Patrick Wingrove (Reuters) – Novo Nordisk said on Tuesday it will stop a trial studying Ozempic to treat kidney failure in diabetes patients ahead of schedule because it was clear from an interim analysis that the treatment would succeed. Novo said the trial would be halted almost a year early based on a recommendation...
New Case Western Reserve University study finds diabetes drug may reduce risk for colorectal cancer
Peer-Reviewed Publication CASE WESTERN RESERVE UNIVERSITY NATHAN BERGER CREDIT: CASE WESTERN RESERVE UNIVERSITY CLEVELAND—A groundbreaking study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC). The findings, published today (Dec. 7) in the journal JAMA Oncology, support...